These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 27213244)
1. Influence of metabolism on endocrine activities of bisphenol S. Skledar DG; Schmidt J; Fic A; Klopčič I; Trontelj J; Dolenc MS; Finel M; Mašič LP Chemosphere; 2016 Aug; 157():152-9. PubMed ID: 27213244 [TBL] [Abstract][Full Text] [Related]
2. Bisphenol A and its analogs: Do their metabolites have endocrine activity? Gramec Skledar D; Peterlin Mašič L Environ Toxicol Pharmacol; 2016 Oct; 47():182-199. PubMed ID: 27771500 [TBL] [Abstract][Full Text] [Related]
3. Suspect and untargeted screening of bisphenol S metabolites produced by in vitro human liver metabolism. Gys C; Kovačič A; Huber C; Lai FY; Heath E; Covaci A Toxicol Lett; 2018 Oct; 295():115-123. PubMed ID: 29908846 [TBL] [Abstract][Full Text] [Related]
4. Estrogenic potency of bisphenol S, polyethersulfone and their metabolites generated by the rat liver S9 fractions on a MVLN cell using a luciferase reporter gene assay. Kang JS; Choi JS; Kim WK; Lee YJ; Park JW Reprod Biol Endocrinol; 2014 Nov; 12():102. PubMed ID: 25371027 [TBL] [Abstract][Full Text] [Related]
5. Profiling of bisphenol S towards nuclear receptors activities in human reporter cell lines. Zenata O; Dvorak Z; Vrzal R Toxicol Lett; 2017 Nov; 281():10-19. PubMed ID: 28916285 [TBL] [Abstract][Full Text] [Related]
6. Effects of bisphenol analogs on thyroid endocrine system and possible interaction with 17β-estradiol using GH3 cells. Lee J; Kim S; Choi K; Ji K Toxicol In Vitro; 2018 Dec; 53():107-113. PubMed ID: 30099086 [TBL] [Abstract][Full Text] [Related]
7. Bisphenol S instead of Bisphenol A: Toxicokinetic investigations in the ovine materno-feto-placental unit. Grandin FC; Lacroix MZ; Gayrard V; Gauderat G; Mila H; Toutain PL; Picard-Hagen N Environ Int; 2018 Nov; 120():584-592. PubMed ID: 30212803 [TBL] [Abstract][Full Text] [Related]
8. In vitro study on the agonistic and antagonistic activities of bisphenol-S and other bisphenol-A congeners and derivatives via nuclear receptors. Molina-Molina JM; Amaya E; Grimaldi M; Sáenz JM; Real M; Fernández MF; Balaguer P; Olea N Toxicol Appl Pharmacol; 2013 Oct; 272(1):127-36. PubMed ID: 23714657 [TBL] [Abstract][Full Text] [Related]
9. [Effect of the Metabolic Modification of Environmental Chemicals on Endocrine-disrupting Activity]. Kitamura S Yakugaku Zasshi; 2018; 138(5):693-713. PubMed ID: 29710015 [TBL] [Abstract][Full Text] [Related]
10. Comparison of the In Vivo Biotransformation of Two Emerging Estrogenic Contaminants, BP2 and BPS, in Zebrafish Embryos and Adults. Le Fol V; Brion F; Hillenweck A; Perdu E; Bruel S; Aït-Aïssa S; Cravedi JP; Zalko D Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28346357 [TBL] [Abstract][Full Text] [Related]
11. Bisphenol S and F: A Systematic Review and Comparison of the Hormonal Activity of Bisphenol A Substitutes. Rochester JR; Bolden AL Environ Health Perspect; 2015 Jul; 123(7):643-50. PubMed ID: 25775505 [TBL] [Abstract][Full Text] [Related]
12. Endocrine disrupting activities and immunomodulatory effects in lymphoblastoid cell lines of diclofenac, 4-hydroxydiclofenac and paracetamol. Klopčič I; Markovič T; Mlinarič-Raščan I; Sollner Dolenc M Toxicol Lett; 2018 Sep; 294():95-104. PubMed ID: 29777833 [TBL] [Abstract][Full Text] [Related]
13. Comparative study of bisphenol A and its analogue bisphenol S on human hepatic cells: a focus on their potential involvement in nonalcoholic fatty liver disease. Peyre L; Rouimi P; de Sousa G; Héliès-Toussaint C; Carré B; Barcellini S; Chagnon MC; Rahmani R Food Chem Toxicol; 2014 Aug; 70():9-18. PubMed ID: 24793377 [TBL] [Abstract][Full Text] [Related]
14. Biotransformation of bisphenol AF to its major glucuronide metabolite reduces estrogenic activity. Li M; Yang Y; Yang Y; Yin J; Zhang J; Feng Y; Shao B PLoS One; 2013; 8(12):e83170. PubMed ID: 24349450 [TBL] [Abstract][Full Text] [Related]
15. A computational approach predicting CYP450 metabolism and estrogenic activity of an endocrine disrupting compound (PCB-30). Harris JB; Eldridge ML; Sayler G; Menn FM; Layton AC; Baudry J Environ Toxicol Chem; 2014 Jul; 33(7):1615-23. PubMed ID: 24687371 [TBL] [Abstract][Full Text] [Related]
16. High concentrations of commonly used drugs can inhibit the in vitro glucuronidation of bisphenol A and nonylphenol in rats. Verner MA; Magher T; Haddad S Xenobiotica; 2010 Feb; 40(2):83-92. PubMed ID: 19916736 [TBL] [Abstract][Full Text] [Related]
17. The occurrence, potential toxicity, and toxicity mechanism of bisphenol S, a substitute of bisphenol A: A critical review of recent progress. Qiu W; Zhan H; Hu J; Zhang T; Xu H; Wong M; Xu B; Zheng C Ecotoxicol Environ Saf; 2019 May; 173():192-202. PubMed ID: 30772709 [TBL] [Abstract][Full Text] [Related]
18. Disposition and metabolism of the bisphenol analogue, bisphenol S, in Harlan Sprague Dawley rats and B6C3F1/N mice and in vitro in hepatocytes from rats, mice, and humans. Waidyanatha S; Black SR; Snyder RW; Yueh YL; Sutherland V; Patel PR; Watson SL; Fennell TR Toxicol Appl Pharmacol; 2018 Jul; 351():32-45. PubMed ID: 29753715 [TBL] [Abstract][Full Text] [Related]
19. Development of an on-line solid phase extraction ultra-high-performance liquid chromatography technique coupled to tandem mass spectrometry for quantification of bisphenol S and bisphenol S glucuronide: Applicability to toxicokinetic investigations. Grandin F; Picard-Hagen N; Gayrard V; Puel S; Viguié C; Toutain PL; Debrauwer L; Lacroix MZ J Chromatogr A; 2017 Dec; 1526():39-46. PubMed ID: 29055528 [TBL] [Abstract][Full Text] [Related]
20. Endocrine activities and adipogenic effects of bisphenol AF and its main metabolite. Skledar DG; Carino A; Trontelj J; Troberg J; Distrutti E; Marchianò S; Tomašič T; Zega A; Finel M; Fiorucci S; Mašič LP Chemosphere; 2019 Jan; 215():870-880. PubMed ID: 30408883 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]